Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 944–945 | Cite as

ASO Author Reflections: Survival Impact of N2 in Non-small Cell Lung Cancer

  • Christelle Clément-DuchêneEmail author
ASO Author Reflections



There are no conflicts of interest.


  1. 1.
    Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. Introduction to the 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart. J Thorac Oncol. 2015;10:1240–2.CrossRefGoogle Scholar
  2. 2.
    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29.CrossRefGoogle Scholar
  3. 3.
    Clément-Duchêne C, Luc A, Casse J-M, et al. Survival impact of stations of pathological lymph nodes in N2 non-small cell lung cancer in a French Hospital. Ann Surg Oncol. 2018;25:1262–8CrossRefGoogle Scholar
  4. 4.
    Baba T, Uramoto H, Kuwata T, et al. Survival impact of node zone classification in resected pathological N2 non–small cell lung cancer. Interact Cardiovasc Thorac Surg. 2012;14:760–4.CrossRefPubMedCentralGoogle Scholar
  5. 5.
    Fernandes AT, Mitra N, Xanthopoulos E, et al. The impact of extent and location of mediastinal lymph node involvement on survival in stage III non–small cell lung cancer patients treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys. 2012;83:340–7.CrossRefGoogle Scholar
  6. 6.
    Guo D, Ni Y, Lv X, Zhang Z, Ye P. Distribution and prognosis of mediastinal lymph node metastases of nonsmall cell lung cancer. J Cancer Res Ther. 2016;12(Suppl):120–5.Google Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Oncology DepartmentInstitut de Cancérologie de LorraineNancyFrance

Personalised recommendations